A comparison of minidose lidocaine-fentanyl and conventional-dose lidocaine spinal anesthesia

Anesthesia and Analgesia

Volumn 91, Issue 4, 2000, Pages 865-870

  Ben David, Bruce ^a   Maryanovsky, Michael ^b   Gurevitch, Alexander ^b   Lucyk, Christen ^a   Solosko, David ^a   Frankel, Roman ^b   Volpin, Gershon ^b   DeMeo, Patrick J ^a  

^a ALLEGHENY GENERAL HOSPITAL   (United States)

^b WESTERN GALILEE HOSPITAL   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

FENTANYL; LIDOCAINE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; HUMAN; KNEE ARTHROSCOPY; LOCAL ANESTHESIA; MAJOR CLINICAL STUDY; MALE; NERVE ROOT; NEUROTOXICITY; OUTPATIENT; PRIORITY JOURNAL; PULSE OXIMETRY; RANDOMIZED CONTROLLED TRIAL; SPINAL ANESTHESIA;

EID: 0033799924     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000539-200010000-00018     Document Type: Article

References (25)

1. Cauda equina syndrome after continuous spinal anesthesia
2. Cauda equina syndrome and continuous spinal anesthesia Anesth Analg
3. Transient neurologic symptoms after spinal anesthesia
4. Transient neurologic toxicity after hyperbaric subarachnoid anesthesia with 5% lidocaine
5. Prospective study of the incidence of transient radicular irritation in patients undergoing spinal anesthesia
6. Transient neurologic symptoms after spinal anesthesia
7. Hyperbaric Lidocaine spinal anesthesia: Do we need an alternative?
8. Persistent sacral sensory deficit induced by intrathecal local anesthetic infusion in the rat
9. Concentration dependence of lidocaine-induced irreversible conduction loss in frog nerve
10. A similar incidence of transient neurologic symptoms after spinal anesthesia with 2% and 5% lidocaine
11. Dilution of spinal lidocaine does not alter the incidence of transient neurologic symptoms
12. Serious complications related to regional anesthesia: Results of a prospective survey in France
13. Spinal Anesthesia: Volume or concentration - What matters?
14. Antinociceptive synergy between intrathecal morphine and lidocaine during visceral and somatic nociception in the rat
15. Local anesthetics potentiate spinal morphine antinociception
16. Specific enhancement by fentanyl of the effects of intrathecal bupivacaine on nociceptive afferent but not on sympathetic efferent pathways in dogs
17. Interaction of intrathecal morphine with bupivacaine and lidocaine in the rat
18. Intrathecal fentanyl with small-dose dilute bupivacaine: Better anesthesia without prolonging recovery
19. Lumbosacral cerebrospinal fluid volume is the primary determinant of sensory block extent and duration during spinal anesthesia
20. Small-dose hypobaric lidocaine-fentanyl spinal anesthesia for short duration outpatient laparoscopy. I. A randomized comparison with conventional dose hyperbaric lidocaine
21. Low dose bupivacaine-fentanyl spinal anesthesia for cesarean delivery
22. Low dose diluted spinal bupivacaine for ambulatory surgery
23. Miniddose bupivacaine-fentanyl spinal anesthesia for surgical repair of hip fracture in the aged
24. Fentanyl prolongs lidocaine spinal anesthesia without prolonging recovery
25. Comparison of 5% with dextrose, and 1.5% dextrose-free lidocaine solutions for spinal anesthesia in human volunteers